Free Account Opening + AMC Free Demat
Loading...

Delhivery IPO vs Supriya Lifescience IPO

Comparision between Delhivery IPO and Supriya Lifescience IPO.

IPO Details

Delhivery IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Delhivery IPO is up to ₹5,235.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Delhivery IPO is ₹487.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.

  Delhivery IPO Supriya Lifescience IPO
Face Value ₹1 per share ₹2 per share
Issue Price (Lower) ₹462.00 per share ₹265.00 per share
Issue Price (Upper) ₹487.00 per share ₹274.00 per share
Issue Price (Final) ₹487.00 per share ₹274.00 per share
Discount (Retail)
Discount (Employee) ₹25.00 per share
Market Lot Size 30 shares 54 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹4,000.00 Cr up to ₹200.00 Cr
OFS Issue Size
OFS Issue Size (Amount) up to ₹1,235.00 Cr up to ₹500.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹5,235.00 Cr up to ₹700.00 Cr

IPO Timetable

Delhivery IPO opens on May 11, 2022, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Delhivery IPO and Supriya Lifescience IPO is May 13, 2022, and Dec 20, 2021, respectively.

  Delhivery IPO Supriya Lifescience IPO
Anchor Bid Date
Issue Open May 11, 2022 Dec 16, 2021
Issue Close May 13, 2022 Dec 20, 2021
Basis Of Allotment (Tentative) May 19, 2022 Dec 23, 2021
Initiation of Refunds (Tentative) May 20, 2022 Dec 24, 2021
Credit of Share (Tentative) May 23, 2022 Dec 27, 2021
Listing date (Tentative) May 24, 2022 Dec 28, 2021
Anchor Lockin End date 1 Jun 18, 2022 Jan 22, 2022
Anchor Lockin End date 2 Aug 17, 2022 Mar 23, 2022

Financials

Delhivery IPO P/E ratio is -67.3, as compared to Supriya Lifescience IPO P/E ratio of .

  Delhivery IPO Supriya Lifescience IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
  31-Dec-21 31-Dec-20 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 84,294.83 47,847.56 45,977.98 43,573.08 40,625.45
Total Revenue 49,114.06 28,065.29 38,382.91 29,886.29 16,948.74
Profit After Tax -8,911.39 -2,974.92 -4,157.43 -2,689.26 -17,833.04
Summary of financial Information (Restated Standalone)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,041.02 4,458.24 3,364.01 2,530.52
Total Revenue 2,300.61 3,962.21 3,227.13 2,858.62
Profit After Tax 659.59 1,238.28 733.74 394.24
Promoter Shareholding (Pre-Issue) 99.98%
Promoter Shareholding (Post-Issue) 68.24%
P/E Ratio -67.3
Market Cap ₹35283.22 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Delhivery IPO retail investors (RII) are offered 1,12,87,878 shares while in Supriya Lifescience IPO retail investors are offered 1,12,87,878 shares. Qualified institutional buyers (QIB) are offered 3,38,63,662 shares in Delhivery IPO and 79,24,527 shares in Supriya Lifescience IPO.

  Delhivery IPO Supriya Lifescience IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 3,38,63,662 shares 79,24,527 shares
NII 1,69,31,818 shares 39,62,263 shares
RII 1,12,87,878 shares 26,41,509 shares
Employee 4,57,665 shares 0 shares
Others
Total 6,25,41,023 shares 1,45,28,299 shares

Bids Received (Subscription)

Delhivery IPO subscribed 1.63x in total, whereas Supriya Lifescience IPO subscribed 71.51x.

  Delhivery IPO Supriya Lifescience IPO
QIB (times) 2.66x 31.83x
NII (times) 0.30x 161.22x
Big NII (times)
Small NII (times)
RII (times) 0.57x 56.01x
Employee (times) 0.27x
Other (times) 0.00x
Total (times) 1.63x 71.51x

Comments

Add a public comment...